
OKW introduces CONNECT enclosures with integrated cable glands. The new CONNECT enclosures simplify cable installation, offering fast assembly with snap-fit design and optional integrated cable glands. Ideal for various sectors including IoT, medical devices, and safety engineering, they are available in multiple sizes and colours, providing flexibility and customisation.

Lawton Tubes appoints new Board Chairman after ten years. Michael Brown, formerly with Dormole Group, will lead the Midlands-based manufacturer from late November. The company, known for its copper tube and fittings, has expanded its international trade significantly, winning prestigious awards and increasing export sales to £26 million.

HIKMICRO has launched a high-performance thermal inspection camera. The SP100H brings higher pixel density, finer thermal sensitivity, and faster workflows to electrical maintenance teams seeking earlier fault detection and safer inspection practices across substations, transmission assets, and generation sites.

SSDL has introduced DuplicatorPlus to modernise legacy SCSI-drive management. The compact unit clones or copies ageing electromechanical media onto CF cards, networked systems or cloud storage, offering a direct migration path into SCSIFlash solid-state replacements without modifying host equipment. It is aimed at sectors still dependent on decades-old embedded platforms.

Schneider Electric partners with NHS to enhance patient care. The collaboration aims to integrate advanced energy-efficient technologies at the National Rehabilitation Centre. This initiative marks a significant step towards achieving the NHS’s net-zero goals, promising improved patient autonomy and reduced operational costs.

Impulse Embedded unveils cutting-edge edge AI systems with Thor. Harnessing NVIDIA’s latest technology, these systems boast significant performance gains, offering up to 2,070 FP4 TFLOPS. This leap in capability supports real-time generative AI and advanced robotics, marking a pivotal advancement in industrial computing solutions.

A novel drug repairs DNA, offering groundbreaking therapeutic potential. Cedars-Sinai researchers have introduced TY1, an experimental drug that repairs DNA damage, heralding a new era in treatment for heart attacks and inflammatory diseases. This development, published in Science Translational Medicine, underscores the drug’s capacity to enhance tissue repair processes.